Literature DB >> 9089429

Structure-affinity relationships for the binding of actinomycin D to DNA.

J Gallego1, A R Ortiz, B de Pascual-Teresa, F Gago.   

Abstract

Molecular models of the complexes between actinomycin D and 14 different DNA hexamers were built based on the X-ray crystal structure of the actinomycin-d(GAAGCTTC)2 complex. The DNA sequences included the canonical GpC binding step flanked by different base pairs, nonclassical binding sites such as GpG and GpT, and sites containing 2,6-diamino-purine. A good correlation was found between the intermolecular interaction energies calculated for the refined complexes and the relative preferences of actinomycin binding to standard and modified DNA. A detailed energy decomposition into van der Waals and electrostatic components for the interactions between the DNA base pairs and either the chromophore or the peptidic part of the antibiotic was performed for each complex. The resulting energy matrix was then subjected to principal component analysis, which showed that actinomycin D discriminates among different DNA sequences by an interplay of hydrogen bonding and stacking interactions. The structure-affinity relationships for this important antitumor drug are thus rationalized and may be used to advantage in design of novel sequence-specific DNA-binding agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089429     DOI: 10.1023/a:1008018106064

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  45 in total

1.  Evidence for sequence preferences in the intercalative binding of ethidium bromide to dinucleoside monophosphates.

Authors:  T R Krugh; C G Reinhardt
Journal:  J Mol Biol       Date:  1975-09-15       Impact factor: 5.469

2.  Site-specific binding constants for actinomycin D on DNA determined from footprinting studies.

Authors:  J Goodisman; R Rehfuss; B Ward; J C Dabrowiak
Journal:  Biochemistry       Date:  1992-02-04       Impact factor: 3.162

3.  The binding of nonintercalative drugs to alternating DNA sequences.

Authors:  F Gago; C A Reynolds; W G Richards
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

4.  Stereochemistry of actinomycin binding to DNA. I. Refinement and further structural details of the actinomycin-deoxyguanosine crystalline complex.

Authors:  S C Jain; H M Sobell
Journal:  J Mol Biol       Date:  1972-07-14       Impact factor: 5.469

5.  MEPSIM: a computational package for analysis and comparison of molecular electrostatic potentials.

Authors:  F Sanz; F Manaut; J Rodríguez; E Lozoya; E López-de-Briñas
Journal:  J Comput Aided Mol Des       Date:  1993-06       Impact factor: 3.686

6.  Binding of actinomycin D to DNA revealed by DNase I footprinting.

Authors:  A V Scamrov; R S Beabealashvilli
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

7.  Sequence specificity of actinomycin D and Netropsin binding to pBR322 DNA analyzed by protection from DNase I.

Authors:  M J Lane; J C Dabrowiak; J N Vournakis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Secondary (non-GpC) binding sites for actinomycin on DNA.

Authors:  K Waterloh; K R Fox
Journal:  Biochim Biophys Acta       Date:  1992-07-15

9.  Sequence-dependent DNA structure. The role of base stacking interactions.

Authors:  C A Hunter
Journal:  J Mol Biol       Date:  1993-04-05       Impact factor: 5.469

10.  Binding specificities of actinomycin D to self-complementary tetranucleotide sequences -XGCY-.

Authors:  F M Chen
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

View more
  4 in total

1.  Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.

Authors:  D Rognan; S Krebs; O Kuonen; J R Lamas; J A López de Castro; G Folkers
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

2.  Contribution of phenylalanine side chain intercalation to the TATA-box binding protein-DNA interaction: molecular dynamics and dispersion-corrected density functional theory studies.

Authors:  Manas Mondal; Sanchita Mukherjee; Dhananjay Bhattacharyya
Journal:  J Mol Model       Date:  2014-10-30       Impact factor: 1.810

3.  Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations.

Authors:  Alaa Elwan; Helmy Sakr; Abdel-Ghany A El-Helby; Ahmed El-Morsy; Mohamed A Abdelgawad; Mohammed M Ghoneim; Mohamed El-Sherbiny; Khaled El-Adl
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Role of stacking interactions in the binding sequence preferences of DNA bis-intercalators: insight from thermodynamic integration free energy simulations.

Authors:  Esther Marco; Ana Negri; F Javier Luque; Federico Gago
Journal:  Nucleic Acids Res       Date:  2005-11-10       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.